Prostate Cancer

Showing NaN - NaN of 158

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in United States (PSMA-PET CT)

Not yet recruiting
  • Prostate Cancer
  • PSMA-PET CT
  • Los Angeles, California
  • +3 more
Jul 6, 2023

Prostate Cancer Trial in United States (drug, device, procedure)

Recruiting
  • Prostate Cancer
  • Administration of IS-002
  • +2 more
  • San Francisco, California
  • +3 more
Jul 7, 2023

Prostate Cancer Trial in San Francisco (MyProstateScore 2.0 Results)

Recruiting
  • Prostate Cancer
  • MyProstateScore 2.0 Results
  • San Francisco, California
    QURE Healthcare
Jun 15, 2023

Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Copper-64 labeled Granzyme B (64Cu-GRIP B)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Jun 7, 2023

Prostate Cancer, Localized Prostate Carcinoma Trial in San Francisco (Hyperpolarized Bicarbonate (13C), Magnetic Resonance

Not yet recruiting
  • Prostate Cancer
  • Localized Prostate Carcinoma
  • Hyperpolarized Bicarbonate (13C)
  • Magnetic Resonance imaging
  • San Francisco, California
    University of California, San Francisco
May 1, 2023

Predicting Cognitive Decline From Androgen Deprivation Therapy

Not yet recruiting
  • Prostate Cancer
  • Blood-based assay
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Apr 20, 2023

Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Mar 1, 2023

Prostate Cancer Trial in United States (DKN-01 300 mg, DKN-01 600 mg, Docetaxel 75 mg/m2)

Terminated
  • Prostate Cancer
  • San Francisco, California
  • +4 more
Jan 30, 2023

Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))

Active, not recruiting
  • Prostate Cancer
  • ARN-509 (Phase 1)
  • ARN-509 (Phase 2)
  • San Diego, California
  • +14 more
Jan 17, 2023

Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

Active, not recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
Jan 17, 2023

Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)

Completed
  • Prostate Cancer
  • 70.2 Gy 3D-CRT/IMRT
  • 79.2 Gy 3D-CRT/IMRT
  • Long Beach, California
  • +85 more
Dec 27, 2022

Prostate Cancer Trial in United States (bicalutamide, goserelin, mitoxantrone HCl)

Completed
  • Prostate Cancer
  • Anchorage, Alaska
  • +233 more
Dec 5, 2022

Failure in Patients Undergoing Radiation Therapy for Localized

Active, not recruiting
  • Prostate Cancer
  • Radiation Toxicity
  • medical chart review
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Dec 9, 2022

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

Prostate Cancer Trial in Canada, United States (Best Systemic Therapy (BST), Best Systemic Therapy (BST) + Surgery or Radiation

Active, not recruiting
  • Prostate Cancer
  • Best Systemic Therapy (BST)
  • +3 more
  • San Francisco, California
  • +3 more
Dec 5, 2022

Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Jonesboro, Arkansas
  • +204 more
Nov 30, 2022

Prostate Cancer Trial in United States (Apalutamide, LHRH Analogue, Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +68 more
Nov 28, 2022

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Prostate Cancer Trial in San Francisco (Prostatic artery embolization)

Not yet recruiting
  • Prostate Cancer
  • Prostatic artery embolization
  • San Francisco, California
    Stanford Cancer Center
Nov 9, 2022

Prostate Cancer Trial in San Francisco (STAND-T platform, Survey Administration, Text Messages)

Recruiting
  • Prostate Cancer
  • STAND-T platform
  • +2 more
  • San Francisco, California
  • +1 more
Oct 26, 2022

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • San Francisco, California
  • +1 more
Oct 8, 2022

Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance

Recruiting
  • Prostate Adenocarcinoma
  • Prostate Cancer
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Oct 3, 2022

Prostate Cancer Trial in Worldwide (Abiraterone, Apitolisib, Ipatasertib)

Completed
  • Prostate Cancer
  • Scottsdale, Arizona
  • +58 more
Sep 7, 2022